These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22335555)

  • 1. 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.
    Ramnauth J; Renton P; Dove P; Annedi SC; Speed J; Silverman S; Mladenova G; Maddaford SP; Zinghini S; Rakhit S; Andrews J; Lee DK; Zhang D; Porreca F
    J Med Chem; 2012 Mar; 55(6):2882-93. PubMed ID: 22335555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.
    Annedi SC; Ramnauth J; Maddaford SP; Renton P; Rakhit S; Mladenova G; Dove P; Silverman S; Andrews JS; Felice MD; Porreca F
    J Med Chem; 2012 Jan; 55(2):943-55. PubMed ID: 22175766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.
    Annedi SC; Maddaford SP; Ramnauth J; Renton P; Rybak T; Silverman S; Rakhit S; Mladenova G; Dove P; Andrews JS; Zhang D; Porreca F
    Eur J Med Chem; 2012 Sep; 55():94-107. PubMed ID: 22840695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.
    Mladenova G; Annedi SC; Ramnauth J; Maddaford SP; Rakhit S; Andrews JS; Zhang D; Porreca F
    J Med Chem; 2012 Apr; 55(7):3488-501. PubMed ID: 22420844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain.
    Annedi SC; Maddaford SP; Mladenova G; Ramnauth J; Rakhit S; Andrews JS; Lee DK; Zhang D; Porreca F; Bunton D; Christie L
    J Med Chem; 2011 Oct; 54(20):7408-16. PubMed ID: 21923116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Ramnauth J; Speed J; Maddaford SP; Dove P; Annedi SC; Renton P; Rakhit S; Andrews J; Silverman S; Mladenova G; Zinghini S; Nair S; Catalano C; Lee DK; De Felice M; Porreca F
    J Med Chem; 2011 Aug; 54(15):5562-75. PubMed ID: 21699209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.
    Payne JE; Bonnefous C; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2010 Nov; 53(21):7739-55. PubMed ID: 20931971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS).
    Annedi SC; Ramnauth J; Cossette M; Maddaford SP; Dove P; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2510-3. PubMed ID: 22370270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma.
    Huang H; Li H; Yang S; Chreifi G; Martásek P; Roman LJ; Meyskens FL; Poulos TL; Silverman RB
    J Med Chem; 2014 Feb; 57(3):686-700. PubMed ID: 24447275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
    van der Stelt M; Cals J; Broeders-Josten S; Cottney J; van der Doelen AA; Hermkens M; de Kimpe V; King A; Klomp J; Oosterom J; Pols-de Rooij I; de Roos J; van Tilborg M; Boyce S; Baker J
    J Med Chem; 2011 Oct; 54(20):7350-62. PubMed ID: 21923175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Zhang L; Pajouhesh H; Jiang X; Hendricson A; Dong H; Tringham E; Ding Y; Vanderah TW; Porreca F; Belardetti F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4153-8. PubMed ID: 22579422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,4-Diaminothienopyrimidines as orally active antimalarial agents.
    González Cabrera D; Le Manach C; Douelle F; Younis Y; Feng TS; Paquet T; Nchinda AT; Street LJ; Taylor D; de Kock C; Wiesner L; Duffy S; White KL; Zabiulla KM; Sambandan Y; Bashyam S; Waterson D; Witty MJ; Charman SA; Avery VM; Wittlin S; Chibale K
    J Med Chem; 2014 Feb; 57(3):1014-22. PubMed ID: 24446664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
    Wiles JA; Phadke AS; Bradbury BJ; Pucci MJ; Thanassi JA; Deshpande M
    J Med Chem; 2011 May; 54(9):3418-25. PubMed ID: 21443219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel.
    Dinges J; Albert DH; Arnold LD; Ashworth KL; Akritopoulou-Zanze I; Bousquet PF; Bouska JJ; Cunha GA; Davidsen SK; Diaz GJ; Djuric SW; Gasiecki AF; Gintant GA; Gracias VJ; Harris CM; Houseman KA; Hutchins CW; Johnson EF; Li H; Marcotte PA; Martin RL; Michaelides MR; Nyein M; Sowin TJ; Su Z; Tapang PH; Xia Z; Zhang HQ
    J Med Chem; 2007 May; 50(9):2011-29. PubMed ID: 17425296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
    Bregman H; Berry L; Buchanan JL; Chen A; Du B; Feric E; Hierl M; Huang L; Immke D; Janosky B; Johnson D; Li X; Ligutti J; Liu D; Malmberg A; Matson D; McDermott J; Miu P; Nguyen HN; Patel VF; Waldon D; Wilenkin B; Zheng XM; Zou A; McDonough SI; DiMauro EF
    J Med Chem; 2011 Jul; 54(13):4427-45. PubMed ID: 21634377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.
    Butini S; Brindisi M; Gemma S; Minetti P; Cabri W; Gallo G; Vincenti S; Talamonti E; Borsini F; Caprioli A; Stasi MA; Di Serio S; Ros S; Borrelli G; Maramai S; Fezza F; Campiani G; Maccarrone M
    J Med Chem; 2012 Aug; 55(15):6898-915. PubMed ID: 22779702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors.
    Annedi SC; Maddaford SP; Ramnauth J; Renton P; Speed J; Rakhit S; Andrews JS; Porreca F
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1980-4. PubMed ID: 22318159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
    Huang H; Silverman RB
    Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management.
    Nelson DW; Frost JM; Tietje KR; Florjancic AS; Ryther K; Carroll WA; Dart MJ; Daza AV; Hooker BA; Grayson GK; Fan Y; Garrison TR; El-Kouhen OF; Yao B; Pai M; Chandran P; Zhu C; Hsieh GC; Meyer MD
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2604-8. PubMed ID: 22370265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.